La Jolla Pharmaceutical Co
LJPCDelisted Aug 22, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000920465
La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in La Jolla Pharmaceutical Co as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +2 vs. Q4 2021
- Shares held
- 16.5M
- −199.6K (−1.2%) vs. Q4 2021
- Total value
- $70.4M
- −$7.20M (−9.3%) vs. Q4 2021
- New holders
- 5
- 6 more added
- Sold out
- 3
- 23 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LJPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 41 | $53.9M |
| Q1 2022 | 45 | $70.4M |
| Q4 2021 | 44 | $77.8M |
| Q3 2021 | 54 | $70.9M |
| Q2 2021 | 62 | $78.6M |
| Q1 2021 | 76 | $88.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding La Jolla Pharmaceutical Co; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 1 | $4 | 0.00% | −30,733−100.0% | Reduced |
| Simplex Trading, LLC | 330 | $1.00K | 0.00% | −1,758−84.2% | Reduced |
| JPMorgan Chase & Co | 388 | $1.00K | 0.00% | −1,163−75.0% | Reduced |
| Royal Bank of Canada | 225 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tyler-Stone Wealth Management | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 594 | $3.00K | 0.00% | −7,533−92.7% | Reduced |
| SOA Wealth Advisors, LLC. | 1,045 | $4.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 1,000 | $4.27K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,218 | $9.00K | 0.00% | −2,209−49.9% | Reduced |
| Wells Fargo & Company | 2,612 | $11.0K | 0.00% | −2,499−48.9% | Reduced |
| Ellis Investment Partners, LLC | 2,800 | $11.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,569 | $15.0K | 0.00% | −5,183−59.2% | Reduced |
| Meeder Asset Management Inc | 4,312 | $18.0K | 0.00% | +4,312 | New |
| Barclays PLC | 5,352 | $23.0K | 0.00% | −12−0.2% | Reduced |
| Bank of America Corp | 6,592 | $28.0K | 0.00% | −7,564−53.4% | Reduced |
| The PNC Financial Services Group, Inc. | 7,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Running Point Capital Advisors, LLC | 10,000 | $43.0K | 0.03% | +10,000 | New |
| Susquehanna International Group, LLP | 11,546 | $49.0K | 0.00% | −36−0.3% | Reduced |
| Occudo Quantitative Strategies LP | 13,541 | $58.0K | 0.00% | −3,635−21.2% | Reduced |
| Goldman Sachs Group Inc | 13,718 | $59.0K | 0.00% | −21,859−61.4% | Reduced |
| Ritholtz Wealth Management | 15,031 | $64.0K | 0.00% | +15,031 | New |
| WealthTrust Axiom LLC | 25,400 | $108.0K | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 26,100 | $111.0K | 0.00% | −9,400−26.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 26,100 | $112.0K | 0.00% | +10,400+66.2% | Added |
| Two Sigma Investments, LP | 27,544 | $118.0K | 0.00% | −60,632−68.8% | Reduced |
| O'Shaughnessy Asset Management, LLC | 33,632 | $144.0K | 0.00% | +33,632 | New |
| Two Sigma Advisers, LP | 34,900 | $149.0K | 0.00% | −25,436−42.2% | Reduced |
| Morgan Stanley | 44,065 | $188.0K | 0.00% | −23,611−34.9% | Reduced |
| Citadel Advisors LLC | 50,873 | $217.0K | 0.00% | −11,104−17.9% | Reduced |
| Northern Trust Corp | 80,053 | $341.0K | 0.00% | +4,047+5.3% | Added |
| Hollencrest Capital Management | 82,355 | $352.0K | 0.03% | 00.0% | Unchanged |
| FMR LLC | 90,441 | $386.0K | 0.00% | +90,441 | New |
| Globeflex Capital L P | 92,799 | $396.0K | 0.08% | 00.0% | Unchanged |
| State Street Corp | 98,941 | $422.0K | 0.00% | +3,962+4.2% | Added |
| Bank of New York Mellon Corp | 127,084 | $543.0K | 0.00% | +5,781+4.8% | Added |
| Millennium Management LLC | 138,889 | $593.0K | 0.00% | −612−0.4% | Reduced |
| Geode Capital Management, LLC | 202,816 | $866.0K | 0.00% | −81,054−28.6% | Reduced |
| Tang Kevin C | 240,000 | $1.02M | 99.61% | 00.0% | Unchanged |
| BlackRock Inc. | 426,513 | $1.82M | 0.00% | −2,256−0.5% | Reduced |
| Acadian Asset Management LLC | 477,688 | $2.04M | 0.01% | +42,301+9.7% | Added |
| D. E. Shaw & Co., Inc. | 600,070 | $2.56M | 0.00% | +11,268+1.9% | Added |
| HealthInvest Partners AB | 707,000 | $3.02M | 4.81% | −123,000−14.8% | Reduced |
| Vanguard Group Inc | 825,481 | $3.52M | 0.00% | −3,962−0.5% | Reduced |
| RTW Investments, LP | 2,327,403 | $9.94M | 0.21% | −5000.0% | Reduced |
| Tang Capital Management LLC | 9,607,934 | $41.0M | 8.30% | 00.0% | Unchanged |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,255−100.0% | Sold out |
| First Midwest Bank Trust Division | – | – | – | – | Not filed |